Oerlemans Foods Siemiatycze
⚠️ High Risk
FEI: 3004435336 • Siemiatycze, Podlaskie • POLAND
FEI Number
3004435336
Location
Siemiatycze, Podlaskie
Country
POLANDAddress
Ul. Armii Krajowej 31, , Siemiatycze, Podlaskie, Poland
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
REFUSE EI
The article is subject to refusal of admission pursuant to Section 801(a)(1) in that the article appears to have been manufactured, processed, or packed under insanitary conditions.
Refusal History
Frequently Asked Questions
What is Oerlemans Foods Siemiatycze's FDA import refusal history?
Oerlemans Foods Siemiatycze (FEI: 3004435336) has 2 FDA import refusal record(s) in our database, spanning from 3/26/2025 to 3/26/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Oerlemans Foods Siemiatycze's FEI number is 3004435336.
What types of violations has Oerlemans Foods Siemiatycze received?
Oerlemans Foods Siemiatycze has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Oerlemans Foods Siemiatycze come from?
All FDA import refusal data for Oerlemans Foods Siemiatycze is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.